131 related articles for article (PubMed ID: 31129146)
1. Body Mass Index and Outcomes in Germ-Cell Tumors.
McGregor BA; Miller RE; O'Donnell E; Albiges LK; Sweeney CJ; Markt SC
Clin Genitourin Cancer; 2019 Aug; 17(4):283-290. PubMed ID: 31129146
[TBL] [Abstract][Full Text] [Related]
2. Age ≥40 Years Is Associated with Adverse Outcome in Metastatic Germ Cell Cancer Despite Appropriate Intended Chemotherapy.
Miller RE; Markt SC; O'Donnell E; Bernard B; Albiges LK; Beard C; Sweeney CJ
Eur Urol Focus; 2017 Dec; 3(6):621-628. PubMed ID: 28753801
[TBL] [Abstract][Full Text] [Related]
3. Site of extranodal metastasis impacts survival in patients with testicular germ cell tumors.
Patel HD; Singla N; Ghandour RA; Freifeld Y; Cheaib JG; Woldu SL; Pierorazio PM; Bagrodia A
Cancer; 2019 Nov; 125(22):3947-3952. PubMed ID: 31355922
[TBL] [Abstract][Full Text] [Related]
4. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features and survival of testicular tumours in a Southeast Asian university hospital: a ten-year review.
Tan GH; Azrif M; Shamsul AS; Ho CC; Praveen S; Goh EH; Bahadzor B; Ismail F; Zulkifli MZ
Asian Pac J Cancer Prev; 2011; 12(10):2727-30. PubMed ID: 22320982
[TBL] [Abstract][Full Text] [Related]
6. Smoking and Disease Outcomes in Patients With Malignant Germ Cell Tumors.
O'Donnell E; Markt SC; Miller R; Bernard B; Albiges L; Beard C; Sweeney C
Clin Genitourin Cancer; 2017 Aug; ():. PubMed ID: 28851592
[TBL] [Abstract][Full Text] [Related]
7. Risk stratification of pubertal children and postpubertal adolescents with clinical stage I testicular nonseminomatous germ cell tumors.
Cost NG; Lubahn JD; Adibi M; Romman A; Wickiser JE; Raj GV; Sagalowsky AI; Margulis V
J Urol; 2014 May; 191(5 Suppl):1485-90. PubMed ID: 24679874
[TBL] [Abstract][Full Text] [Related]
8. Histologic type, staging, and distribution of germ cell tumors in Korean adults.
Park DS; Chung MK; Chung JI; Ahn HJ; Lee ES; Choi HY; Yoon DK; Cheon J; Hong SJ; Lee YG; Yoon SM; Kim WJ; Kim HJ; Ryu SB; Ro JY
Urol Oncol; 2008; 26(6):590-4. PubMed ID: 18367106
[TBL] [Abstract][Full Text] [Related]
9. Conditional Survival of Patients With Metastatic Testicular Germ Cell Tumors Treated With First-Line Curative Therapy.
Ko JJ; Bernard B; Tran B; Li H; Asif T; Stukalin I; Lee M; Day D; Alimohamed N; Sweeney CJ; Bedard PL; Heng DY
J Clin Oncol; 2016 Mar; 34(7):714-20. PubMed ID: 26786931
[TBL] [Abstract][Full Text] [Related]
10. Factors that impact the outcomes in testicular germ cell tumors in low-middle-income countries.
Saju SV; Radhakrishnan V; Ganesan TS; Dhanushkodi M; Raja A; Selvaluxmy G; Sagar TG
Med Oncol; 2019 Feb; 36(3):28. PubMed ID: 30725328
[TBL] [Abstract][Full Text] [Related]
11. Autologous Stem-Cell Transplantation Outcomes for Relapsed Metastatic Germ-Cell Tumors in the Modern Era.
Hamid AA; Markt SC; Vicier C; McDermott K; Richardson P; Ho VT; Sweeney CJ
Clin Genitourin Cancer; 2019 Feb; 17(1):58-64.e1. PubMed ID: 30309761
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of tumor marker decline as an independent prognostic factor in patients with relapsed metastatic germ-cell tumors.
Mego M; Rejlekova K; Reckova M; Sycova-Mila Z; Obertova J; Rajec J; Mardiak J
Neoplasma; 2009; 56(5):398-403. PubMed ID: 19580341
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Patients With Sertoli and Leydig Cell Testis Neoplasms From a National Population-Based Registry.
Osbun N; Winters B; Holt SK; Schade GR; Lin DW; Wright JL
Clin Genitourin Cancer; 2017 Apr; 15(2):e263-e266. PubMed ID: 27594555
[TBL] [Abstract][Full Text] [Related]
14. Testicular germ cell tumors with sarcomatous components: an analysis of 33 cases.
Guo CC; Punar M; Contreras AL; Tu SM; Pisters L; Tamboli P; Czerniak B
Am J Surg Pathol; 2009 Aug; 33(8):1173-8. PubMed ID: 19561445
[TBL] [Abstract][Full Text] [Related]
15. A comparison of pediatric, adolescent, and adult testicular germ cell malignancy.
Cost NG; Lubahn JD; Adibi M; Romman A; Wickiser JE; Raj GV; Sagalowsky AI; Margulis V
Pediatr Blood Cancer; 2014 Mar; 61(3):446-51. PubMed ID: 24106160
[TBL] [Abstract][Full Text] [Related]
16. Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer.
Olofsson SE; Nodin B; Gaber A; Eberhard J; Uhlén M; Jirström K; Jerkeman M
PLoS One; 2015; 10(3):e0121300. PubMed ID: 25811459
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.
Balzer BL; Ulbright TM
Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of late relapse on surveillance in patients presenting with clinical stage I testicular cancer.
Rice KR; Beck SD; Pedrosa JA; Masterson TA; Einhorn LH; Foster RS
Urology; 2014 Oct; 84(4):886-90. PubMed ID: 25260450
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-lymphocyte ratio as a predictor of preoperative tumor staging in testicular germ cell tumors.
Jankovich M; Jankovichova T; Ondrus D; Breza J
Bratisl Lek Listy; 2017; 118(9):510-512. PubMed ID: 29061055
[TBL] [Abstract][Full Text] [Related]
20. Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration.
Kildahl-Andersen A; Erke MG; Sagstuen H; Bremnes RM
Acta Oncol; 2005; 44(6):537-44. PubMed ID: 16165912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
